Skip to Content

MYLAN 2035 MYLAN 2035 (Topiramate (Sprinkle) 15 mg)

Pill with imprint MYLAN 2035 MYLAN 2035 is Pink, Capsule-shape and has been identified as Topiramate (Sprinkle) 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of migraine prevention; fibromyalgia; bipolar disorder; seizures; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2035 MYLAN 2035

Topiramate (Sprinkle)

Imprint:
MYLAN 2035 MYLAN 2035
Strength:
15 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2035

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide